Randox Laboratories Ltd-医療機器分野:企業M&A・提携分析

◆英語タイトル:Randox Laboratories Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010926
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Randox Laboratories Ltd (Randox) is a clinical diagnostic company that manufactures and provides clinical diagnostic solutions to laboratories. The company’s products include biochip analyzers, biochip immunoassays, clinical chemistry analyzers and diagnostic reagents among others. It offers diagnostic, prognostic and predictive solutions for cardiovascular disease, infectious disease and cancer. Randox also provides testing services. Its products find application in various areas including hospital laboratories; clinical, research and molecular laboratories; forensic toxicology laboratories; food testing laboratories; and life sciences and veterinary laboratories. The company has its manufacturing and research and development (R&D) facilities in Ireland, India, the UK and the US. Randox is headquartered in Antrim, the UK.

Randox Laboratories Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Randox Laboratories Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Randox Laboratories Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Randox Laboratories Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Randox Laboratories Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Randox Laboratories Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Randox Laboratories Ltd, Medical Equipment, Deal Details 10
Partnerships 10
University of Surrey Enters Into Licensing Agreement With Randox For Engrailed-2 Biomarker 10
Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test 11
Aterovax Enters Into Licensing Agreement With Randox For sPLA2 Test 12
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 13
Randox Laboratories Ltd – Key Competitors 14
Randox Laboratories Ltd – Key Employees 15
Randox Laboratories Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Product News 18
Jan 06, 2017: Randox supports calls from Oxford University for more accurate diagnosis of diabetes following report warning 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Randox Laboratories Ltd, Medical Equipment, Key Facts, 2015 2
Randox Laboratories Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Randox Laboratories Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Randox Laboratories Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Randox Laboratories Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Randox Laboratories Ltd, Deals By Market, 2011 to YTD 2017 8
Randox Laboratories Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
University of Surrey Enters Into Licensing Agreement With Randox For Engrailed-2 Biomarker 10
Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test 11
Aterovax Enters Into Licensing Agreement With Randox For sPLA2 Test 12
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 13
Randox Laboratories Ltd, Key Competitors 14
Randox Laboratories Ltd, Key Employees 15
Randox Laboratories Ltd, Other Locations 16
Randox Laboratories Ltd, Subsidiaries 16

★海外企業調査レポート[Randox Laboratories Ltd-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Servier Canada Inc-製薬・医療分野:企業M&A・提携分析
    Summary Servier Canada Inc (SCI), a subsidiary of Les Laboratoires Servier SAS is a manufacturer and distributor of generic and ethical products. The company’s products include perindopril erbumine tablets, perindopril erbumine indaparride tablets, glidazide modified release tablets, glidazide table …
  • West African Development Bank:電力:M&Aディール及び事業提携情報
    Summary West African Development Bank (BOAD) is a public financial institution focused on the balanced development of its member countries of the West African Monetary Union (WAMU). The institution offers financial advisory services; guarantees of bond loans; financial assistance in project preparat …
  • Dr. Reddy’s Research and Development BV-製薬・医療分野:企業M&A・提携分析
    Summary Dr. Reddy’s Research and Development BV (Dr. Reddy’s Research and Development), a subsidiary of Dr. Reddy's Laboratories Ltd is a drug formulation and manufacturing service provider that develops and manufactures improved injectable pharmaceuticals. The company offers services such as formul …
  • Ausgrid:企業の戦略的SWOT分析
    Ausgrid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Proteome Sciences Plc (PRM):企業の財務・戦略的SWOT分析
    Proteome Sciences Plc (PRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • UTStarcom Holdings Corp. (UTSI):企業の財務・戦略的SWOT分析
    UTStarcom Holdings Corp. (UTSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Chubu Electric Power Co Inc (9502):石油・ガス:M&Aディール及び事業提携情報
    Summary Chubu Electric Power Co Inc (Chubu) is an energy utility. It generates and procures electricity; and offers electric network related services. The company produces electricity using hydro, thermal, nuclear and renewable sources. Chubu has interests in upstream and midstream energy fields. It …
  • Empresa De Telecomunicaciones De Bogota S.A. E.S.P. (ETB):企業の財務・戦略的SWOT分析
    Empresa De Telecomunicaciones De Bogota S.A. E.S.P. (ETB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the compan …
  • Ck Hutchison Holdings Ltd:企業の戦略・SWOT・財務分析
    Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Trinity Biotech Plc (TRIB):医療機器:M&Aディール及び事業提携情報
    Summary Trinity Biotech Plc (Trinity Biotech) is a medical equipment company which develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company’s product portfolio encompasses diagnostic tests and instruments that are used to dete …
  • Hitec Power Protection BV:企業の戦略的SWOT分析
    Hitec Power Protection BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • British Business Bank Plc:企業の戦略的SWOT分析
    British Business Bank Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • International Montoro Resources Inc (IMT):企業の財務・戦略的SWOT分析
    Summary International Montoro Resources Inc (International Montoro) is a mining and mineral exploration company. The company provides acquisition, exploration, and development of nickel, copper, cobalt, gold, rare earth elements and uranium mineral prospects, among others. It offers property such as …
  • Triodos Bank NV:企業の戦略・SWOT・財務情報
    Triodos Bank NV - Strategy, SWOT and Corporate Finance Report Summary Triodos Bank NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Liebherr-International AG:企業の戦略・SWOT・財務分析
    Liebherr-International AG - Strategy, SWOT and Corporate Finance Report Summary Liebherr-International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Bank Frick & Co. AG:企業の戦略・SWOT・財務情報
    Bank Frick & Co. AG - Strategy, SWOT and Corporate Finance Report Summary Bank Frick & Co. AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cantex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cantex Pharmaceuticals Inc (Cantex), formerly ParinGenix Inc is a clinical stage biopharmaceutical company that focuses on the development of proprietary pharmaceuticals for the treatment of cancers and other disorders. The company's pipeline products include CX-01, a proprietary combination …
  • Nippon Flour Mills Co., Ltd.:企業の戦略・SWOT・財務分析
    Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Flour Mills Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • AbGenomics International Inc-製薬・医療分野:企業M&A・提携分析
    Summary AbGenomics International Inc (AbGenomics) is a biopharmaceutical company that develops therapeutics for inflammatory diseases and cancers. The company provides products such as pipeline products, monoclonal antibody products, therapeutic products, neihulizumab, bio-therapeutics, and biobette …
  • Dimerix Bioscience Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Dimerix Bioscience Pty Ltd (Dimerix), a subsidiary of Sun Biomedical Ltd is a biopharmaceutical company that offers drug discovery assays and progressing clinical programs. The company provides product development, discovery services, and others. It provides Receptor-HIT a cell-based assay a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆